Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

Diagnosis at stages 1-3 increases cancer survival rate significantly

January 25, 2019 Medical Communications Cancer, England, NHS, health, oncology

Adults diagnosed with stage 1 skin, prostate or breast cancer have the same chance of still being alive the following …
News
nhs_sign

NHS App begins public rollout across England following successful testing

January 24, 2019 Medical Communications England, NHS, NHS App, UK, health, pharma

NHS England has announced that the NHS app, which will allow patients to book and manage their GP appointments alongside …
News
antibiotic_sensitvity_and_resistance

UK government launches plan to control AMR by 2040

January 24, 2019 Medical Communications, Research and Development AMR, Antibiotics, Davos, Matt Hancock, UK

The British government has announced a plan through which it will incentivise pharmaceutical companies to develop drugs aimed at tackling …
News
mesothelioma

Pushing for progress in mesothelioma

January 21, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, mesothelioma, pharma

Mesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as …
Feature
sun-pharma-759

Sun Pharma’s shares hit six-year low after further whistleblower allegations emerge

January 18, 2019 Medical Communications India, Sun Pharma, pharma

Sun Pharma has seen its shares fall by 12% to an almost six-year low after it was rocked by allegations …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

January 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Netherlands, Novo Nordisk, Roche, astra zeneca, prcing, sequiris, top 10, uk politics

Job switches were the theme of this week as AstraZeneca lost three, high levels executives to biotechs amid a restructuring …
News

Pharmacists warn of shortages in England

January 18, 2019 Medical Communications access, pharmacists, pricing, shortages

Pharmacists in England have warned that they are struggling to obtain many common generic medicines, as the number of medicines …
News
novartis_window

Canada Health approves Novartis’ CAR-T therapy Kymriah

January 18, 2019 Medical Communications CAR T, CAR-T, Canada, Cancer, Kymriah, Novartis, oncology

Health Canada has approved Novartis’ CAR-T therapy Kymriah for use in paediatric and young adult patients aged between three and …
News

Abbvie’s chronic lymphocytic leukaemia drug Venclytxo scores greenlight from NICE

January 18, 2019 Medical Communications, Sales and Marketing AbbVie, NHS, NICE, Venclyxto, leukaemia, pharma

A new recommendation from NICE means that thousands of patients in England and Wales will be able to receive Abbvie’s …
News

More young people surviving cancer in England, despite significant economic divide

January 17, 2019 Medical Communications, Research and Development Cancer, England, UK, health public health, oncology, young people

Mortality and five year survival rates in a range of different cancers among people aged 13-24 improved in England between …
News
novo_flag

Novo Nordisk Pharmatech A/S signs distribution agreement with DKSH for eleven markets in Asia Pacific

January 16, 2019 Manufacturing and Production, Medical Communications, Research and Development DKSH, Novo Nordisk, pharma

DKSH’s Business Unit Performance Materials, a leading ingredients and specialty chemicals distributor, will distribute Novo Nordisk Pharmatech’s pharmaceutical grade compounds …
News
douglas_watson

Former CEO of Novartis’ US operations joins board of cancer immunotherapy firm

January 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

ImmunSYS, a Fort Lauderdale, Florida-based firm focused on the development of innovative cancer immunotherapy products, today announced that Douglas G …
Appointment
sean_bohen

AstraZeneca’s chief medical officer announces resignation amid wave of departures

January 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

AstraZeneca’s Sean Bohen has announced he will step down from his role as chief medical officer at the Anglo-Swedish drugmaker …
Appointment
nve00002_web

Living with Alström syndrome

January 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alström syndrome, patient experience, pharma, rare disease

Kay Parkinson lived the tragedy of seeing both of her children born with an ultra-rare condition, and the elusiveness of …
Feature
artificial-intelligence-2228610_640

Kyowa Hakko Kirin signs drug discovery deal with AI firm InveniAI

January 11, 2019 Medical Communications, Research and Development AI, InveniAI, Kyowa Hakko Kirin, artificial intelligence, drug discovery, pharma

Japanese pharma and biotech firm Kyowa Hakko Kirin is joining the growing trend of investing in artificial intelligence to bolster …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025